Xenon Pharmaceuticals: Strong Buy On Azetukalner NDA And MDD Expansion Opportunity (XENE)
· seekingalpha.com
Xenon Pharma (XENE) upgraded to Strong Buy after positive phase 3 X-TOLE2 seizure data for azetukalner. Read the latest analysis on the stock here.
This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you ...